Rare diseases present daunting challenges for researchers and clinicians. With limited data and resources available, developing effective treatments can feel like trying to solve a complex puzzle with missing pieces. However, Shweta Maniar, Director of Global Healthcare & Life Sciences Industry Strategy at Google Cloud, believes there is hope - and it comes in the form of Generative AI.  Listeners will come away with a deeper understanding of how this transformative technology can crack the code of rare diseases and unlock a future of better outcomes for patients in critical need. Copy

• How this innovative technology can revolutionize rare disease research
• The unique capabilities of Generative AI models 
• How they differ from traditional machine learning, enabling breakthroughs in areas like accelerating research, improving patient diagnosis, and streamlining treatment development
• Real-world case studies demonstrating the impact of Generative AI
• Ethical considerations that must be navigated

Shweta Maniar, Director of Global Healthcare & Life Sciences Industry Strategy, Google Cloud

Megan Antonelli, Chief Executive Officer, HealthIMPACT Live